Simone Krebs, MD, MS
Nuclear Medicine Physician
PET/CT; General Diagnostic and Therapeutic Nuclear Medicine
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Albert-Ludwigs-University, Freiburg, Germany
Nuclear Medicine - University of Freiburg, Germany; Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
Molecular Imaging and Therapy - Memorial Sloan Kettering Cancer Center
I am an American Board of Nuclear Medicine–certified physician-scientist trained in molecular imaging and targeted radiotherapy. I have extensive experience in nuclear medicine and adoptive cell therapy and frequently work with colleagues across departments at Memorial Sloan Kettering Cancer Center to take an interdisciplinary approach to disease management.
My research leverages my training in translational and clinical research and currently focuses on tracking adoptively transferred cells and evaluating theranostic approaches (imaging combined with targeted therapy) for neuroendocrine and brain tumors, and for other cancers. Through my research, I hope to contribute to the exciting field of radiotheranostics, with a focus on T cell therapy, which is starting to show its great potential to improve outcomes for people with cancer.
Awards and Honors
- NIH R37 (MERIT) Award ( 2021)
- SNMMI “One to Watch”
- Annual list of 30 early career professionals selected by Society of Nuclear Medicine and Molecular Imaging (SNMMI) (2021)
- EANM Springer Prize 2020 - EJNMMI Best Paper (“Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors”) (2020)
- NIH SPORE Lymphoma Career Enhancement Program Award (2020)
- Larry E. Kun, MD Award of Academic Excellence and Dedication to Cures (2018
- Advanced Certificate in Clinical & Translational Investigation (Weill Cornell Graduate School) (2016)
- NIH K12 Paul Calabresi Career Development Award for Clinical Oncology (2016)
- Best Poster – Travel Grant for “First in-Human Trial of Dasatinib-Tracer PET Imaging: Preliminary Results in Cancer Patients” at the ACNM Annual Meeting and SNMMI Mid-Winter Meeting San Antonio, TX, January 22, 2015 (2015)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Krebs’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Simone Krebs discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.